Skip to main content
Premium Trial:

Request an Annual Quote

Isis Division Receives $1.5M in Homeland Security Contracts for Microbial Forensics Technology

NEW YORK, April 18 (GenomeWeb News) - Isis Pharmaceuticals announced today that its Ibis division has been granted two new contracts, worth a total of $1.5 million, from the Department of Homeland Security Science and Technology Directorate.

 

According to Isis, the contracts will fund Ibis' development of a new microbial forensics application of the company's TIGER (Triangulation Identification for Genetic Evaluation of Risks) biosensor system.

 

Microbial forensics involves comparing the genetic fingerprint of an infectious agent to that of a potential source, said Isis.

 

The contracts will also be used to add new genetic information on infectious agents to the Microbial Rosetta Stone database, a component of the TIGER system.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.